Atrial Fibrillation
Atrial Fibrillation - most related articles:
-
Stroke survivors with irregular heartbeat may have higher risk of dementia - 13.4
-
Anticoagulant Dabigatran effective in atrial fibrillation patients - 11.3
-
Rivaroxaban can prevent strokes in atrial fibrillation patients - 10.6
-
Heart disorder linked to Alzheimer's disease dementia - 10.3
-
Ablation heart procedure reduces risk of Alzheimer and stroke - 10.1
-
Cholesterol drug statins may reduce heart's atrial fibrillation - 9.6
-
Sanofi's Multaq approved to treat heart rhythm disorder, US - 9.1
-
Plavix reduced major vascular events by 11% in heart disease - 8
-
Anticoagulant Dabigatran linked to heart attack or MI - 6.9
-
Stroke risk greater for older women with atrial fibrillation - 5.8
Atrial Fibrillation articles
Stroke risk greater for older women with atrial fibrillationIn a study that examined use of the anticoagulant medication warfarin and risk of stroke following a diagnosis of atrial fibrillation in older patients, women, especially those 75 years or older, had a higher risk of stroke than men, regardless of their risk profile and use of warfarin, suggesting that current anticoagulant therapy to prevent stroke might not be sufficient for older women.
Rivaroxaban can prevent strokes in atrial fibrillation patientsRivaroxaban, an anti-clotting drug, was shown to be an attractive alternative to warfarin in the prevention of stroke in patients with atrial fibrillation, revealed by researchers recently.
Stroke survivors with irregular heartbeat may have higher risk of dementiaStroke survivors who have an irregular heartbeat called atrial fibrillation may be at higher risk of developing dementia than stroke survivors who do not have the heart condition, according to research published in the March 8, 2011, print issue of Neurology®, the medical journal of the American Academy of Neurology.
Ablation heart procedure reduces risk of Alzheimer and strokeResearchers found that ablation treatment can eliminate serious risks associated with atrial fibrillation. New research was presented at National Heart Rhythm Society.
Catheter treatment works better than drugs for heart rhythm disorderTreating a common heart rhythm disorder by burning heart tissue with a catheter works dramatically better than drug treatments, according to a landmark study published in the Jan. 27 issue of the Journal of the American Medical Association (JAMA).
Anticoagulant Dabigatran effective in atrial fibrillation patientsThe anticoagulant dabigatran is more effective than warfarin in the prevention of stroke in patients with atrial fibrillation, revealed by researchers in a study RE-LY (Randomized Evaluation of Long-term anticoagulant therapY).
Sanofi's Multaq approved to treat heart rhythm disorder, USThe U.S. Food and Drug Administration has approved Sanofi's Multaq tablets (dronedarone) to help maintain normal heart rhythms in patients with a history of atrial fibrillation or atrial flutter (heart rhythm disorders or arrhythmia).
Heart disorder linked to Alzheimer's disease dementiaResearchers at Intermountain Medical Center in Salt Lake City believe that they have made a breakthrough connection between atrial fibrillation, a fairly common heart rhythm disorder, and Alzheimer's disease, the leading form of dementia among Americans.
Plavix reduced major vascular events by 11% in heart diseasePlavix plus aspirin more effective than aspirin alone in preventing major vascular events in patients with atrial fibrillation who cannot take oral anticoagulants.
Cholesterol drug statins may reduce heart's atrial fibrillationWhen we're young, a racing heart often means love is in the air. If you're a "baby boomer," it might mean you've just joined the 2.2 million Americans who have atrial fibrillation (AF), an irregularity in the heart's rhythm that grows more common as we age and markedly increases the risk for stroke.
10 Atrial Fibrillation articles listed above.
Mission
Health Newstrack is dedicated to serve recent and updated health & medical research, events/news, views/reviews to its subscribers and free access to general public, health & medical professionals, and other health seekers worldwide online with a user-friendly system.